Elite Pharmaceuticals, Inc. Impairment of Intangible Assets (Excluding Goodwill)
Elite Pharmaceuticals, Inc. (ELTP) reported Impairment of Intangible Assets (Excluding Goodwill) of $847.01 thousand for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill · last filed 2026-06-29
- Elite Pharmaceuticals, Inc. impairment of intangible assets (excluding goodwill) for fiscal 2026 was $847.01K, a 47.17% decline from fiscal 2025.
- Elite Pharmaceuticals, Inc. impairment of intangible assets (excluding goodwill) for fiscal 2025 was $1.60M.
| Period end | Impairment of Intangible Assets (Excluding Goodwill) 12 month |
|---|---|
| 2026-03-31 | $847.01K 10-K · filed 2026-06-29 |
| 2025-03-31 | $1.60M 10-K · filed 2026-06-29 |